Exosome MI RNA profiling and sequencing service

Ended Purchase Order Awarded Last action

Contract number
75F40123P00431
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · The purpose of this modification is to DE-obligate funds and close out the contract. -$16,514
Original award $16,514

About this award

The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $16,514 purchase order to Arraystar Inc. to provide exosome miRNA profiling and sequencing services. The firm fixed price contract has a period of performance from September 19, 2023 through April 25, 2024 and will be performed in Silver Spring, Maryland. Arraystar will deliver the requested exosome profiling and sequencing services to support HHS FDA programs. No subcontractors or set aside designations were identified. The contract award aligns with the HHS FDA's focus on advancing precision medicine and developing new diagnostics through exosome and small RNA research.

Quick answers

Who was awarded contract 75F40123P00431?

75F40123P00431 was awarded to Arraystar Inc. by Food and Drug Administration (Department of Health and Human Services) on September 19, 2023.

How much is contract 75F40123P00431 worth?

The government has obligated $0 on 75F40123P00431.

Was contract 75F40123P00431 competed?

The extent of competition for 75F40123P00431 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award